Evidence Hub

Macular Telangiectasia Type 2 and Unilateral Subfoveal Vitelliform Lesion: A Longitudinal Follow-up By Multimodal Imaging

Ali H, Karti O, Ayhan Z, Oflaz AB, Saatci AO

Romanian journal of ophthalmology, 2026

Abstract

Macular telangiectasia type 2 (MacTel type 2) is a bilateral, acquired macular disorder that typically manifests in middle-aged individuals. Circular, yellowish subretinal deposits distinguish a vitelliform lesion (VL) and are very rarely observed in conjunction with MacTel type 2. The presence of VL in cases of MacTel type 2 may further contribute to visual deterioration and lead to misdiagnosis. We report the case of a 54-year-old, otherwise healthy man with MacTel type 2 and unilateral VL, in whom the VL lesion progressed to macular atrophy during a three-year follow-up period.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free